Inventor · disambiguated record
Toufike Kanouni
Also filed as: KANOUNI TOUFIKE
87 granted patents·17 pending applications·249 citations·filing 2006–2025
99Inventor score
Files withCELGENE QUANTICEL RES INC54KINNATE BIOPHARMA INC23QUANTICEL PHARMACEUTICALS INC12FORWARD THERAPEUTICS INC6TAKEDA PHARMACEUTICAL3
Top patents by PatentIndex Score
104 records- 0198US9255097B2Inhibitors of lysine specific demethylase-1QUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 9, 2016·29 cites·30 claims
- 0297US10927111B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·9 cites·29 claims
- 0397US9447045B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·20 cites·16 claims
- 0496US11407737B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Aug 9, 2022·8 cites·30 claims
- 0596US11098031B1Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2020·Granted Aug 24, 2021·12 cites·30 claims
- 0696US11084793B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2020·Granted Aug 10, 2021·3 cites·24 claims
- 0796US9573930B2Inhibitors of lysine specific demethylase-1QUANTICEL PHARMACEUTICALS INC·Filed 2016·Granted Feb 21, 2017·15 cites·16 claims
- 0896US8952151B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Feb 10, 2015·21 cites·18 claims
- 0995US11377431B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Jul 5, 2022·7 cites·30 claims
- 1095US11345681B1Inhibitors of fibroblast growth factor receptor kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted May 31, 2022·4 cites·19 claims
- 1195US9643965B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·6 cites·5 claims
- 1294US11780862B2Inhibitors of MEK kinaseKINNATE BIOPHARMA INC·Filed 2023·Granted Oct 10, 2023·2 cites·27 claims
- 1394US11535616B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 27, 2022·2 cites·13 claims
- 1493US10316016B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Jun 11, 2019·4 cites·8 claims
- 1593US10112940B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 30, 2018·4 cites·6 claims
- 1693US9085534B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Jul 21, 2015·8 cites·34 claims
- 1792US10815234B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 27, 2020·2 cites·9 claims
- 1892US10208039B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 19, 2019·4 cites·8 claims
- 1992US10202381B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 12, 2019·4 cites·24 claims
- 2092US10047069B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 14, 2018·4 cites·3 claims
- 2191US12312336B2Inhibitors of RAF kinasesPF MEDICAMENT·Filed 2021·Granted May 27, 2025·2 cites·20 claims
- 2291US10894788B2Inhibitors of cyclin-dependent kinasesKINNATE BIOPHARMA INC·Filed 2019·Granted Jan 19, 2021·5 cites·29 claims
- 2391US10030017B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Jul 24, 2018·4 cites·4 claims
- 2491US9771329B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Sep 26, 2017·6 cites·19 claims
- 2591US9133166B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2014·Granted Sep 15, 2015·10 cites·17 claims
- 2690US10703739B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2019·Granted Jul 7, 2020·2 cites·11 claims
- 2790US10654810B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted May 19, 2020·2 cites·19 claims
- 2890US10023543B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Jul 17, 2018·4 cites·2 claims
- 2990US2025066355A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2024·Application pending·0 cites
- 3089US11753395B2Inhibitors of MET kinaseKINNATE BIOPHARMA INC·Filed 2022·Granted Sep 12, 2023·1 cites·30 claims
- 3189US11746095B2Inhibtors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2022·Granted Sep 5, 2023·1 cites·10 claims
- 3289US11020380B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jun 1, 2021·2 cites·27 claims
- 3389US10611763B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Apr 7, 2020·2 cites·7 claims
- 3489US9776974B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 3, 2017·4 cites·19 claims
- 3588US11890275B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2021·Granted Feb 6, 2024·1 cites·44 claims
- 3688US11214542B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jan 4, 2022·1 cites·17 claims
- 3788US9828358B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Nov 28, 2017·5 cites·20 claims
- 3887US8969343B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Mar 3, 2015·3 cites·21 claims
- 3987US2023286917A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2023·Application pending·0 cites
- 4086US11667634B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Jun 6, 2023·1 cites·8 claims
- 4186US10807956B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 20, 2020·1 cites·18 claims
- 4286US10207999B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Feb 19, 2019·2 cites·2 claims
- 4385US12172998B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2022·Granted Dec 24, 2024·0 cites·13 claims
- 4485US10617680B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2018·Granted Apr 14, 2020·3 cites·48 claims
- 4585US9725441B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 8, 2017·2 cites·20 claims
- 4683US10597365B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Mar 24, 2020·1 cites·14 claims
- 4783US9822119B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2015·Granted Nov 21, 2017·3 cites·20 claims
- 4883US2025250293A1Inhibitors of mek kinaseMOSAICA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4982US12122800B2Inhibitors of MEK kinaseKINNATE BIOPHARMA INC·Filed 2023·Granted Oct 22, 2024·0 cites·16 claims
- 5082US10385051B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Aug 20, 2019·2 cites·45 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Toufike Kanouni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →